What is the recommended first‑line treatment for serous (glue) otitis media in children?

Treatment of Serous Otitis Media in Children

Watchful waiting for 3 months is the recommended first-line treatment for children with serous otitis media who are not at risk for developmental complications, as 75-90% of cases resolve spontaneously without intervention. 1, 2

Initial Management: Observation Period

• All children without risk factors should be managed with observation for 3 months from the date of effusion onset (if known) or from diagnosis (if onset is unknown). 1, 2, 3

• During this period, monitor using pneumatic otoscopy or tympanometry at clinician discretion to document the presence and persistence of middle ear effusion. 1, 3

• Parents should be counseled that the child may experience reduced hearing (typically 25 dB hearing level on average, with 20% exceeding 35 dB) until the effusion resolves, and strategies to optimize the listening environment should be recommended. 2, 4

• Nasal balloon auto-inflation should be used during the watchful waiting period due to its low cost, absence of adverse effects, and positive outcomes (NNT = 9 for clearing middle ear effusion at 3 months). 2, 4

Medical Therapies: What NOT to Use

The American Academy of Otolaryngology-Head and Neck Surgery and American Academy of Pediatrics make strong negative recommendations against several commonly used medications:

• Do not use antihistamines or decongestants for treating serous otitis media—they are ineffective with a relative risk of 0.99 (95% CI 0.92-1.05) and increase side effects (NNH 16.6). 1, 2, 3, 5

• Do not use systemic or intranasal corticosteroids—they have no long-term benefit and may cause adverse effects including behavioral changes, increased appetite, and weight gain. 1, 2, 3

• Do not use systemic antibiotics—they are not effective for routine management of serous otitis media and do not have long-term efficacy. 1, 3

This represents a critical pitfall: despite their popularity in practice, these medications provide no meaningful benefit and expose children to unnecessary side effects. 1, 5

When to Obtain Hearing Testing

• Obtain age-appropriate hearing testing if OME persists for 3 months or longer, or at any time that language delay, learning problems, or significant hearing loss is suspected. 1, 2, 3

• Children with bilateral OME and documented hearing loss should receive counseling about the potential impact on speech and language development. 3

Surgical Intervention: Tympanostomy Tubes

Tympanostomy tube insertion is the preferred initial surgical procedure when surgery becomes indicated after the 3-month observation period. 1, 2, 3

Indications for Surgery:

• Bilateral effusions persisting ≥3 months with documented hearing loss (16-40 dB HL). 2, 4

• Chronic OME with structural changes of the tympanic membrane (atrophy, retraction). 2, 4

• Type B (flat) tympanogram indicating persistent fluid or negative pressure after 3 months. 2, 4

Age-Specific Surgical Recommendations:

• For children <4 years old: Tympanostomy tubes alone are recommended. Adenoidectomy should NOT be performed unless a distinct indication exists (nasal obstruction, chronic adenoiditis) separate from the OME itself. 2, 3

• For children ≥4 years old: Tympanostomy tubes, adenoidectomy, or both may be considered. For repeat surgery, adenoidectomy plus myringotomy (with or without tube insertion) is recommended, unless the child has a cleft palate. 2, 3

Expected Outcomes:

• Tympanostomy tubes provide high-level evidence of benefit for hearing and quality of life for up to 9 months. 4

• Hearing improvement of 6-12 dB while tubes are patent. 4

• Tubes clear middle ear effusion for up to 2 years. 4

• Important caveat: Tympanostomy tubes have NO evidence of beneficial effect on language development. 4

Special Populations: At-Risk Children

Children with the following conditions may require earlier or more aggressive intervention and should be monitored more closely:

• Down syndrome (requires hearing assessments every 6 months starting at birth). 2, 4

• Cleft palate (nearly universal occurrence of OME, requires multidisciplinary management throughout childhood). 2, 4

• Craniofacial syndromes or developmental disabilities. 1, 2

• Severe visual impairments. 2

These at-risk children may be offered tympanostomy tubes before the standard 3-month observation period. 2, 4

Follow-Up and Monitoring

• Reevaluate children with chronic OME at 3- to 6-month intervals until the effusion resolves, significant hearing loss is identified, or structural abnormalities of the eardrum or middle ear are suspected. 1, 2, 3

• After tympanostomy tube placement, evaluate within 3 months and then periodically while tubes remain in place. 2

• Educate caregivers about tube function duration, follow-up schedule, and how to detect complications such as otorrhea. 2

Management of Underlying Allergies

• For patients with OME secondary to allergic rhinitis, treat the underlying allergies with intranasal corticosteroids as first-line therapy for the allergic rhinitis itself (not for the OME). 2

• Second-generation antihistamines can be used for sneezing and itching associated with allergic rhinitis. 2

This distinction is crucial: intranasal corticosteroids are appropriate for treating allergic rhinitis that may be contributing to OME, but they are NOT effective for treating the OME directly. 2, 3